Ременс

General characteristics. Structure:

Active ingredients: 17,9 mg of Tsimitsifugi (Cimicifuga) D1, 37,2 mg of the Sanguinaria of Canadian (Sanguinaria) D6, 37,2 mg of Jaborandi of D6, 37,2 mg of a secret of D12 Sepia gland, 37,2 mg of poison of a snake Surukuku (Lachesis) D12.

Excipients: lactoses monohydrate, potato starch, magnesium stearate.

Indications to use:

Complex treatment of disturbances of a menstrual cycle (premenstrual syndrome, dysmenorrhea and secondary amenorrhea), menopausal syndrome, endometritis, adnexitis.

Route of administration and doses:

For ensuring the greatest efficiency РЕМЕНС® it is necessary to accept in 30 minutes prior to or in 1 hour after meal, to keep a tablet under language to a full rassasyvaniye.

Disturbances of a menstrual cycle (premenstrual syndrome, dismenoreya secondary amenorrhea Dose (one-time) Frequency rate of reception Adults and teenagers 1 tablet 3 times a day 3 months. If necessary the course of treatment can be repeated in 1 month after consultation with the doctor. Menopausal syndrome: Dose (one-time) Frequency rate of reception Adults 1 tablet 3 times a day not less than 6 months. At stabilization of a state transition to 1-2 one-time reception in day. Chronic inflammatory diseases of a female genital Dose (one-time) Frequency rate of reception Adults and teenagers 1 tablet 3 times a day 3 months. If necessary the course of treatment can be repeated in 1 month after consultation with the doctor.

In acute cases reception everyone half an hour-hour before improvement of a state, but no more than 8 times is possible then to accept 3 times a day.

Features of use:

Use at pregnancy and in the period of a lactation: at pregnancy and in the period of a lactation drug is used on doctor's orders.

Side effects:

Currently emergence of side effects is not registered.

Interaction with other medicines:

Clinically significant interaction of drug with other medicines is not established.

Contraindications:

Hypersensitivity to drug components.

Overdose:

Overdose cases were not registered so far.

Storage conditions:

At a temperature not above 25 °C in the place protected from light. To store in the places unavailable to children. Period of storage 3 years. Not to apply after the period of validity specified on packaging.

Issue conditions:

Without recipe

Packaging:

On 12 tablets in the blister from aluminum foil and PVH/PVDH. On 1, 2, 3 or 4 blisters place together with the instruction on a medical use in a cardboard pack.